发明名称 MOLECULAR CHAPERONE EXPRESSION INDUCER
摘要 <p>Disclosed is a pharmaceutical composition having an activity of inducing the expression of an endoplasmic reticulum chaperone, which can be used effectively for the prevention of the cell death caused by endoplasmic reticulum stress or for the prevention of occurrence or progression of a neurodegenerative disease or the amelioration of a neurodegenerative disease. The pharmaceutical composition comprises a compound represented by the formula (I), a pharmaceutically acceptable salt thereof, or a solvate of the compound or the salt, as an active ingredient. (I) wherein R&lt;SUP&gt;1&lt;/SUP&gt; and R&lt;SUP&gt;2&lt;/SUP&gt; independently represent a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkyl group or a lower alkoxy group; Alk represents a lower alkylene chain; and X represents an oxygen atom or a sulfur atom.</p>
申请公布号 WO2007125720(A1) 申请公布日期 2007.11.08
申请号 WO2007JP57046 申请日期 2007.03.30
申请人 OSAKA UNIVERSITY;UNIVERSITY OF MIYAZAKI;SHIONOGI & CO., LTD.;KUDO, TAKASHI;IMAIZUMI, KAZUNORI;TAKEDA, MASATOSHI 发明人 KUDO, TAKASHI;IMAIZUMI, KAZUNORI;TAKEDA, MASATOSHI
分类号 A61K31/26;A61P3/10;A61P9/10;A61P25/00;A61P25/16;A61P25/28;A61P27/06;A61P43/00 主分类号 A61K31/26
代理机构 代理人
主权项
地址